Biochemical and pharmacologic rationale for the development of a synthetic heparin pentasaccharide

被引：94

作者：

Walenga, JM ^{[1
]}

Jeske, WP ^{[1
]}

Bara, L ^{[1
]}

Samama, MM ^{[1
]}

Fareed, J ^{[1
]}

机构：

[1] HOP HOTEL DIEU, DEPT BIOL HAEMATOL, PARIS, FRANCE

来源：

THROMBOSIS RESEARCH | 1997年 / 86卷 / 01期

关键词：

heparin; pentasaccharide; antithrombin; factor Xa; antithrombotic;

D O I：

10.1016/S0049-3848(97)00042-X

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1 / 36

页数：36

共 140 条

[31]

Choay J, 1981, Ann N Y Acad Sci, V370, P644, DOI 10.1111/j.1749-6632.1981.tb29770.x

[32]

CONARD J, 1983, HAEMOSTASIS, V13, P363

[33]

CREPON B, 1993, THROMB HAEMOSTASIS, V69, P654

[34] ANTICOAGULANT ACTION OF HEPARIN [J].

DAMUS, PS ;

HICKS, M ;

ROSENBERG, RD .

NATURE, 1973, 246 (5432) :355-357

[35]

DOL F, 1993, THROMB HAEMOSTASIS, V69, P655

[36]

DUNWIDDIE C, 1989, J BIOL CHEM, V264, P16694

[37] IMPORTANCE OF FACTOR-XA IN DETERMINING THE PROCOAGULANT ACTIVITY OF WHOLE-BLOOD CLOTS [J].

EISENBERG, PR ;

SIEGEL, JE ;

ABENDSCHEIN, DR ;

MILETICH, JP .

JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (05) :1877-1883

[38]

ELALAMY I, 1995, THROMB HAEMOSTASIS, V74, P1384

[39]

ERDJUMENT H, 1988, J BIOL CHEM, V263, P5589

[40]

FAREED J, 1989, ANN NY ACAD SCI, V556, P333

← 1 2 3 4 5 6 7 8 9 10 →